Carlo Patrono Selected Research

edoxaban

10/2020

Low-Dose Edoxaban for Stroke Prevention in Elderly Patients with Atrial Fibrillation: Comment on the Edoxaban Low-Dose for Elder Care Atrial Fibrillation Patients (ELDERCARE-AF) Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carlo Patrono Research Topics

Disease

23	Thrombosis (Thrombus) 02/2024 - 01/2002
15	Neoplasms (Cancer) 02/2024 - 02/2002
14	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 01/2003
12	Hemorrhage 01/2023 - 01/2004
9	Inflammation (Inflammations) 06/2023 - 10/2002
9	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 02/2002
7	Type 2 Diabetes Mellitus (MODY) 02/2024 - 03/2004
7	Atrial Fibrillation 01/2023 - 08/2013
7	Myocardial Infarction 01/2023 - 01/2004
7	Essential Thrombocythemia 12/2022 - 04/2006
6	Stroke (Strokes) 01/2023 - 01/2004
6	Polycythemia Vera 12/2022 - 01/2004
6	COVID-19 02/2022 - 12/2020
4	Body Weight (Weight, Body) 02/2024 - 10/2002
4	Pain (Aches) 01/2023 - 01/2014
4	Heart Failure 01/2022 - 03/2016
4	Acute Coronary Syndrome 05/2021 - 02/2004
3	Carcinogenesis 01/2023 - 10/2016
3	Neoplasm Metastasis (Metastasis) 01/2023 - 05/2016
3	ST Elevation Myocardial Infarction 01/2023 - 05/2016
3	Venous Thrombosis (Deep-Vein Thrombosis) 12/2022 - 01/2004
3	Diabetes Mellitus 10/2022 - 11/2019
3	Coronary Disease (Coronary Heart Disease) 10/2020 - 04/2005
3	Vascular Diseases (Vascular Disease) 11/2019 - 05/2009
3	Obesity 01/2017 - 10/2002
2	Adenoma (Adenomas) 01/2023 - 10/2020
2	Fibrosis (Cirrhosis) 01/2022 - 01/2019
2	Venous Thromboembolism 10/2021 - 07/2015
2	Chronic Renal Insufficiency 01/2021 - 11/2020
2	Atherosclerosis 02/2020 - 06/2010
2	Ischemic Stroke 11/2019 - 02/2004
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2016 - 07/2003
2	Adenomatous Polyps 04/2012 - 02/2002
2	Weight Loss (Weight Reduction) 12/2006 - 10/2002
2	Insulin Resistance 12/2006 - 01/2005
2	Diabetic Angiopathies (Diabetic Angiopathy) 01/2005 - 07/2003
2	Vascular System Injuries 10/2004 - 10/2002
1	Cardiotoxicity 11/2023
1	Heart Diseases (Heart Disease) 01/2023
1	Fever (Fevers) 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2023
1	Rheumatic Heart Disease (Rheumatic Heart Diseases) 01/2023
1	Rheumatoid Arthritis 01/2022

Drug/Important Bio-Agent (IBA)

42	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2024 - 01/2002
16	ThromboxanesIBA 02/2024 - 07/2003
9	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2019 - 01/2004
8	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2023 - 01/2003
7	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2020 - 02/2002
6	11-dehydro-thromboxane B2IBA 01/2023 - 10/2002
4	AnticoagulantsIBA 01/2023 - 05/2016
4	ProstaglandinsIBA 01/2023 - 10/2002
3	CreatinineIBA 02/2024 - 10/2002
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2023 - 02/2020
3	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2021 - 09/2006
3	Dinoprostone (PGE2)FDA Link 10/2020 - 05/2016
3	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2019 - 02/2016
3	AntioxidantsIBA 08/2010 - 03/2004
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2010 - 10/2002
3	Oxidants (Oxidizing Agents)IBA 04/2005 - 10/2002
3	8-epi-prostaglandin F2alphaIBA 01/2005 - 11/2002
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2020
2	Vitamin K FDA Link 01/2023 - 05/2016
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2005
2	Factor XIa (Coagulation Factor XIa)IBA 01/2022 - 01/2022
2	Arachidonic Acid (Vitamin F)IBA 01/2021 - 09/2006
2	Cyclooxygenase 1IBA 01/2019 - 02/2010
2	LipidsIBA 01/2019 - 12/2018
2	HomocysteineIBA 03/2016 - 09/2012
2	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 03/2016 - 09/2012
2	antineoplaston A10 (A 10)IBA 01/2016 - 04/2012
2	C-Reactive ProteinIBA 12/2006 - 10/2002
2	CD40 Ligand (CD40L)IBA 12/2006 - 01/2006
2	Celecoxib (Celebrex)FDA Link 09/2006 - 02/2002
2	IsoprostanesIBA 04/2005 - 01/2005
1	AlbuminsIBA 02/2024
1	tirzepatideIBA 02/2024
1	Atorvastatin (Lipitor)FDA Link 11/2023
1	AnthracyclinesIBA 11/2023
1	CholesterolIBA 06/2023
1	Cyclooxygenase InhibitorsIBA 01/2023
1	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 01/2023
1	acivicin (AT 125)IBA 01/2023
1	Allopurinol (Remid)FDA LinkGeneric 01/2023
1	bivalirudin (Angiomax)FDA Link 01/2023
1	Proton Pump InhibitorsIBA 10/2022
1	Heparin (Liquaemin)FDA LinkGeneric 02/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	Glucagon-Like Peptides (Enteroglucagon)IBA 01/2022
1	Antirheumatic Agents (DMARD)IBA 01/2022
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 10/2021
1	abelacimabIBA 10/2021
1	Glucagon-Like Peptide-1 ReceptorIBA 10/2021

Therapy/Procedure

20	Therapeutics 03/2023 - 01/2005
6	Secondary Prevention 01/2022 - 05/2009
4	Chemoprevention 10/2020 - 03/2008
2	Contraindications 04/2006 - 01/2004
1	Deprescriptions 01/2023
1	Transcatheter Aortic Valve Replacement 01/2023
1	Mediterranean Diet 01/2022